Issue Date: October 6, 2014
Generics Makers Fight Label Change
Generic drug makers are threatening to sue if the Food & Drug Administration finalizes a proposal to revamp warning labels on their products. They contend the planned regulation could jeopardize patient safety and access to affordable medicines.
As proposed, “the rule is bad policy and bad for public health,” says Ralph G. Neas, CEO of the Generic Pharmaceutical Association, the industry’s main trade group. If it . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society